Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective
Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary dysfunctional disease, characterized by progressive vascular remodeling. Inflammation is an increasingly recognized feature of PAH, which is important for the initiation and maintenance of vascular remodeling. High levels of various i...
Saved in:
Main Authors: | Ran-ran Wang (Author), Tian-yi Yuan (Author), Jian-mei Wang (Author), Yu-cai Chen (Author), Jiu-liang Zhao (Author), Meng-tao Li (Author), Lian-hua Fang (Author), Guan-hua Du (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dan-Shen-Yin Granules Prevent Hypoxia-Induced Pulmonary Hypertension via STAT3/HIF-1α/VEGF and FAK/AKT Signaling Pathways
by: Ran-Ran Wang, et al.
Published: (2022) -
CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats
by: Hua Guan, et al.
Published: (2021) -
Text Mining-Based Drug Discovery for Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
by: Jiang-Shan Tan, et al.
Published: (2022) -
Obesity and Pulmonary Hypertension: A Review of Pathophysiologic Mechanisms
by: Scott E. Friedman, et al.
Published: (2012) -
Bosentan for Treatment of Pediatric Idiopathic Pulmonary Arterial Hypertension: State-of-the-Art
by: Yuchen Wang, et al.
Published: (2019)